ENTRY       D11882                      Drug
NAME        Copper Cu 64 dotatate;
            Detectnet (TN)
PRODUCT     DETECTNET (CURIUM US LLC)
FORMULA     C65H86CuN14O19S2. 2H
EXACT_MASS  1495.5088
MOL_WEIGHT  1497.1526
REMARK      ATC code: V09IX15
            Product: D11882<US>
EFFICACY    Diagnostic (neuroendocrine tumors), Radioactive agent
COMMENT     Indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs)
TARGET      SSTR2 [HSA:6752] [KO:K04218]
  PATHWAY   hsa04080(6752)  Neuroactive ligand-receptor interaction
            hsa04935(6752)  Growth hormone synthesis, secretion and action
            hsa04971(6752)  Gastric acid secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V09 DIAGNOSTIC RADIOPHARMACEUTICALS
               V09I TUMOUR DETECTION
                V09IX Other diagnostic radiopharmaceuticals for tumour detection
                 V09IX15 Copper (64Cu) dotatate
                  D11882  Copper Cu 64 dotatate &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Somatostatin
                SSTR2
                 D11882  Copper Cu 64 dotatate &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11882
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11882
DBLINKS     CAS: 1426155-87-4
///
